Turkey is a key destination for cirrhosis treatment, with hospitals like Hisar Hospital Intercontinental, Medipol Mega University Hospital, and Memorial Şişli Hospital accredited by the Joint Commission International (JCI). Hisar Hospital Intercontinental attracts over 500,000 patients annually, while Medipol Mega University Hospital uses advanced technology like the Da Vinci Surgical System. Memorial Şişli Hospital has a 90% success rate in organ transplants.
Innovative cirrhosis treatments in Turkey include liver transplantation, TIPS, radiofrequency ablation, and endoscopic variceal ligation. The 5-year survival rate after a liver transplant in Turkey reaches up to 78%, aligning with international rates due to precise diagnostics and personalized treatment plans.